Embleton M J
Br J Cancer Suppl. 1973 Aug;1:142-52.
A microcytotoxicity assay was used to detect cell mediated immunity against colon and rectum carcinoma cells in vitro. Lymphocytes from 62% of colon carcinoma patients were cytotoxic for the cells, but no cross reactions between colon carcinomata and tumours of other types were observed. The effect of papain solubilized tumour membrane extracts was evaluated by testing lymphocytes for reactivity following preincubation with the extracts. Soluble preparations of pooled colon carcinomata inhibited cytotoxicity by sensitized lymphocytes, but similar extracts of normal colon or melanoma had no inhibitory effect. The results suggest that soluble tumour antigen may play a role in abolishing lymphocyte reactivity, and this supports the concept that cellular immunity against tumours in may be inhibited by circulating antigen.
采用微量细胞毒性试验在体外检测针对结肠和直肠癌细胞的细胞介导免疫。62%的结肠癌患者的淋巴细胞对这些细胞具有细胞毒性,但未观察到结肠癌与其他类型肿瘤之间的交叉反应。通过检测淋巴细胞与木瓜蛋白酶溶解的肿瘤膜提取物预孵育后的反应性来评估其效果。合并的结肠癌可溶性制剂可抑制致敏淋巴细胞的细胞毒性,但正常结肠或黑色素瘤的类似提取物无抑制作用。结果表明,可溶性肿瘤抗原可能在消除淋巴细胞反应性中起作用,这支持了循环抗原可能抑制体内针对肿瘤的细胞免疫的概念。